K152932

Substantially Equivalent

BlastGen

Applicant: Origio A/S
Product code: MQL
Advisory panel: Obstetrics/Gynecology
Date received: 2015-10-05
Decision date: 2016-02-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Måløv, DK

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.